STAT3 and prostate carcinoma: GlcN decreased STAT3 activation to reduce the expression of anti-apoptosis protein, surviving, in prostate carcinoma DU145 cells (39); impaired the stemness of human aldehyde dehydrogenase-positive breast cancer stem cells (40).